Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Leedjonesgable: Oncolytics Biotech Inc. | ONCY/ONC-TSX

<< Previous

Bullboard Posts

Next >>

Comment by Noteableon Sep 08, 2023 6:31pm

128 Views

Post# 35627052

RE:RE:Leedjonesgable: Oncolytics Biotech Inc. | ONCY/ONC-TSX

So why would LeedJomesGable have some entity investing US$ 17.5 million at this point? Well either that entity is covering a hugh short position OR that entity sees the unrealized value in the stock right now!

<< Previous

Bullboard Posts

Next >>

The top TSX healthcare stocks under $1